What is SMG's relative strength rating?

SMG ranks at the 14th percentile over 1 month, 54th percentile over 3 months, 31th percentile over 6 months, 45th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is SMG in?

SMG is classified under the Healthcare sector within the Chemicals industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is SMG in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). SMG benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

SMG currently shows a 20-day average daily range (ADR%) of 4.0%, a 90-day beta versus the S&P 500 of 0.65. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does SMG have a seasonal pattern?

TickerStance computes SMG's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what SMG has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did SMG last report earnings?

SMG most recently filed a 10-Q covering FY26 Q3 with the SEC on 2026-08-05. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

The Scotts Miracle-Gro Company (SMG) · RS 31

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, The Scotts Miracle-Gro Company (SMG) has a 3-month relative strength percentile of 54 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.0%, relative volume 0.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month54pctile

6 month31pctile

1 year45pctile

Classic43IBD pctile

LDR51leadership

0 of 5 lenses lit · avg RS pctile 45

!ADR%4.0%!A/DD!RVOL0.94×✓$ Vol$65M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthJan on averageavg +13.46% · 75% win · n 4

Worst monthAug on averageavg -13.96% · 0% win · n 4

SMG monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	SMG Jan avg: 13.46% median: 8.51% win: 75% σ: 25.31% n: 4 2022-04-12 → 2026-07-31	SMG Feb avg: 5.70% median: 11.73% win: 75% σ: 15.76% n: 4 2022-04-12 → 2026-07-31	SMG Mar avg: -5.37% median: -9.78% win: 25% σ: 13.20% n: 4 2022-04-12 → 2026-07-31	SMG Apr avg: -5.71% median: -8.11% win: 20% σ: 5.51% n: 5 2022-04-12 → 2026-07-31	SMG May avg: -0.07% median: -5.40% win: 40% σ: 10.94% n: 5 2022-04-12 → 2026-07-31	SMG Jun avg: 0.44% median: -0.81% win: 40% σ: 12.95% n: 5 2022-04-12 → 2026-07-31	SMG Jul avg: 7.32% median: 11.72% win: 60% σ: 11.18% n: 5 2022-04-12 → 2026-07-31	SMG Aug avg: -13.96% median: -14.40% win: 0% σ: 9.95% n: 4 2022-04-12 → 2026-07-31 (current)	SMG Sep avg: -7.44% median: -7.88% win: 25% σ: 23.82% n: 4 2022-04-12 → 2026-07-31	SMG Oct avg: -3.08% median: -2.85% win: 50% σ: 9.12% n: 4 2022-04-12 → 2026-07-31	SMG Nov avg: 10.37% median: 13.81% win: 75% σ: 16.79% n: 4 2022-04-12 → 2026-07-31	SMG Dec avg: -2.37% median: -5.03% win: 50% σ: 13.72% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

14

3m

54

6m

31

1y

45

LDR

—

StageWeinstein stage analysis

Stage 3 · Topping

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · SMG

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q3 · period end 2026-06-27

32

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 36

View fundamental leadership map

Average

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

Contracting

−$4.21—

24 Q4

−$1.21—

25 Q1

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
SMG
54RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Chemicals

Same industry, closest relative strength

4 peers · by RS6M

ECVTEcovyst Inc.32 ACNTAscent Industries Co. Common Stock31 FULH.B. Fuller Company32 CECelanese Corporation Common Stock30

ETF OWNERS

ETFs holding SMG

SMG appears in 1 ETF as of Jun 2026: WBIY at 1.47% weight, $867K notional.

Held by 111 ETFs · $546M across latest filings · largest weight 2.85% (DIVY).

ETFs holding: 1
Total value: $867K
Top 3 concentration: 100.0%
Max weight: WBIY · 1.47%

Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.

ETFs holding SMG ranked by value
ETF	Weight	Value	Δ
WBIY	1.47%	$867K	new

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · SMG

Is the crowd watching?

61/ 100 · vs its own 90-day norm▲ 18 vs 7dRetail trap

Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

What Scotts Miracle-Gro (SMG)'s Fiduciary Probe and Lawsuit After 2023 Results Mean For Shareholders - simplywall.st · simplywall.st

Reference

Company snapshot

SectorHealthcare

IndustryChemicals

SIC2870

Float44.6Mshares

Shares out58.2Mshares

Market cap$3.5BMid Cap

FAQ

Frequently asked questions

What is SMG's relative strength rating?: SMG ranks at the 14th percentile over 1 month, 54th percentile over 3 months, 31th percentile over 6 months, 45th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is SMG in?: SMG is classified under the Healthcare sector within the Chemicals industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is SMG in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). SMG benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is SMG?: SMG currently shows a 20-day average daily range (ADR%) of 4.0%, a 90-day beta versus the S&P 500 of 0.65. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does SMG have a seasonal pattern?: TickerStance computes SMG's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what SMG has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

The Scotts Miracle-Gro Company (SMG) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding SMG

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

The Scotts Miracle-Gro Company (SMG) — Stance & relative strength

SMG is not confirmed as a leader. 54 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding SMG

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?